10x Genomics, Inc. TXG Asia-Pacific (excluding China) — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s asia-pacific (excluding china) — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s asia-pacific (excluding china) — revenue?
- 10x Genomics, Inc. (TXG) reported asia-pacific (excluding china) — revenue of $18.06M in Q1 2026.
- How has 10x Genomics, Inc.'s asia-pacific (excluding china) — revenue changed year-over-year?
- 10x Genomics, Inc.'s asia-pacific (excluding china) — revenue increased by 16.2% year-over-year, from $15.54M to $18.06M.
- What is the long-term trend for 10x Genomics, Inc.'s asia-pacific (excluding china) — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s asia-pacific (excluding china) — revenue has grown at a 7.4% compound annual growth rate (CAGR), from $39.11M to $52.07M.
- What does asia-pacific (excluding china) — revenue mean?
- This metric represents the total net sales generated from customers located in the Asia-Pacific region, specifically excluding operations within China. It serves as a key indicator of the company's market penetration and adoption rates for its life science technology solutions within this specific geographic territory. Tracking this revenue stream helps investors assess the company's ability to scale its international footprint and diversify its customer base outside of its primary markets.